Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Reduced noradrenaline use
Locations
1
Netherlands
Amsterdam UMC, location AMC
Amsterdam, Netherlands
Start Date
October 1, 2022
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2028
Last Updated
March 27, 2026
NCT07052799
NCT03854071
NCT05198791
NCT04419480
NCT06744322
NCT07301034
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions